Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure | Zendy

Lars Køber | Zendy; Jens Jakob Thune | Zendy; Jens Cosedis Nielsen | Zendy; Jens Haarbo | Zendy; Lars Videbæk | Zendy; Eva Korup | Zendy; Gunnar V.H. Jensen | Zendy; Per Hildebrandt | Zendy; Flemming Hald Steffensen | Zendy; Niels Eske Bruun | Zendy; Hans Eiskjær | Zendy; Axel Brandes | Zendy; Anna Margrethe Thøgersen | Zendy; Finn Gustafsson | Zendy; Kenneth Egstrup | Zendy; R. Videbæk | Zendy; Christian Hassager | Zendy; Jesper Hastrup Svendsen | Zendy; Dan Eik Høfsten | Zendy; Christian TorpPedersen | Zendy; Steen Pehrson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Author(s) -

Lars Køber,

Jens Jakob Thune,

Jens Cosedis Nielsen,

Jens Haarbo,

Lars Videbæk,

Eva Korup,

Gunnar V.H. Jensen,

Per Hildebrandt,

Flemming Hald Steffensen,

Niels Eske Bruun,

Hans Eiskjær,

Axel Brandes,

Anna Margrethe Thøgersen,

Finn Gustafsson,

Kenneth Egstrup,

R. Videbæk,

Christian Hassager,

Jesper Hastrup Svendsen,

Dan Eik Høfsten,

Christian TorpPedersen,

Steen Pehrson

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1608029

Subject(s) - medicine , heart failure , hazard ratio , ejection fraction , cardiology , coronary artery disease , sudden cardiac death , cardiac resynchronization therapy , implantable cardioverter defibrillator , randomized controlled trial , sudden death , confidence interval

The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research